2022
DOI: 10.1177/15569845221130800
|View full text |Cite
|
Sign up to set email alerts
|

The ATLAS Trial: A Look Before We LeAAPS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…Hopefully, a definitive answer on the role of preventive LAAC in patients undergoing cardiac surgery for another indication will be provided by the Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction (LeAAPS) (NCT05478304) [ 82 ] that will evaluate thromboembolic events in 6500 patients with increased risk for stroke and AF, randomly assigned to LAAC with AtriClip or not. Evaluation at follow-up of results of surgical closure, however, will not be included in the primary outcomes [ 83 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hopefully, a definitive answer on the role of preventive LAAC in patients undergoing cardiac surgery for another indication will be provided by the Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction (LeAAPS) (NCT05478304) [ 82 ] that will evaluate thromboembolic events in 6500 patients with increased risk for stroke and AF, randomly assigned to LAAC with AtriClip or not. Evaluation at follow-up of results of surgical closure, however, will not be included in the primary outcomes [ 83 ].…”
Section: Discussionmentioning
confidence: 99%
“…Based on the presented data, another multicenter prospective study called LeAAPS was commenced. It aims to ultimately answer the question of concomitant surgical LAAO in patients with no AF [15].…”
Section: Left Atrial Appendage As a Legitimate Target For Thromboembo...mentioning
confidence: 99%
“…Although studies have explored the benefits of LAAC in patients with AF, there remains a paucity of evidence regarding its efficacy in patients without underlying AF. 14 , 15 , 16 This gap in knowledge is critical because many patients undergoing cardiac surgery may not have documented AF preoperatively, yet at the same time, may have elevated CHA 2 -DS 2 -VASc score and thromboembolic risk. It has been also speculated that LAAC may serve as bailout for patients developing postoperative AF (POAF) after cardiac surgery to reduce embolic risk and POAF-related stroke burden.…”
mentioning
confidence: 99%